|
M
|
MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 ActiveScientific & Education |
2018-12-05
Private limited company (Ltd.)
CZ207139
Research and experimental development on biotechnology (7211)
Scientific & Education
Research
Education & Training
Nonprofit Organisations
Charities
MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 is based at VIA TOMMASO CAMPANELLA, 115, Italy and is a Private limited company (Ltd.) company. The company initiated trading on 5 December 2018. MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3’s status is Active. The company’s registration number is CZ207139. Their main business activity is Research and experimental development on biotechnology.
All Finance Company Information of MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3
The most recent company financial report for MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3, submitted on 2020-12-31, shows a Turnover of €41,353.00 and a Working-Capital of -€14,527.00. MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3’s Profit-after-Tax is -€19,251.00. The company announced a Turnover decrease of 73.98%, equivalent to 71947 compared to the previous year. Concurrently, their Working-Capital went up by -37309 or 156.83%.
MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 Business Credit Report
A Credit Report MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 is available for instant download. When we generate this report, we took into account that the company is 4 year old, Turnover €41,353.00, Working-Capital -€14,527.00 and the Profit-after-Tax of -€19,251.00, we took into account if there are any outstanding mortgages or Court Judgements and checked if the industry which the company is trading, Research and experimental development on biotechnology, is considered a high level of corporate failures.
MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3
Unlock Credit Report
For more information you can
Key features
-
Credit Score and Credit Limit
-
Financial accounts for the past 5 years
-
Credit Officers
-
Document Filing history
-
Corporate Ownership
-
Outstanding & Satisfied Mortgages
-
Shareholder Information
- Company Identity
Competitor Information for MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3
CORION BIOTECH S.R.L., DIANAX S.R.L., KITOS BIOTECH S.R.L. S., ATPR&D S.R.L. - IN LIQUIDAZIONE, S.C.F. STUDIO DI CONSULENZA FARMACOLOGICA S.R.L., are the main 5 competitors for MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3. By upgrading your Global Database account, you’ll have access to the entire MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 competitor list and can export all the data. Click here to upgrade.
CORION BIOTECH S.R.L.
DIANAX S.R.L.
KITOS BIOTECH S.R.L. S.
ATPR&D S.R.L. - IN LIQUIDAZIONE
S.C.F. STUDIO DI CONSULENZA FARMACOLOGICA S.R.L.
Turnover
MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 submitted their most recent account statements. The statements report a turnover of €41,353.00. This is a 73.98% increase year-over-year.
italy.globaldatabase.com
2020-12-31
What is the address of MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3?
The registered office of MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 is at: VIA TOMMASO CAMPANELLA, 115, Italy.
What is the revenue of MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3?
The company made €41,353.00 for 2020. This amount is an increase of 73.98%.Their latest financial accounts were submitted on 2020-12-31.
Does MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 have a business credit score? If so, how do I find it?
Yes. When you purchase a business credit report for MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3, you will see the company’s business credit score. You’ll also have access to information about the company’s most recent ownership, credit limit information, group structure, court judgements, and much more.
Can I find out if MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3 pays the company’s invoices on time?
On the business credit report, you’ll be able to view the payment trends of MEDIFARMAGEN S.R.L. START-UP COSTITUITA A NORMA DELL ART. 4 COMMA 10 BIS DEL DECRETO LEGGE 24 GENNAIO 2015 N. 3.
Search for International Credit Report
One report
-
Credit Rating and Limit Recomendations
-
5 years of financial statements
-
Directors and shareholders
-
Court Judgements
-
Global Group Structure
-
Trade Payment
Unlimited reports
-
Everything include in one report, plus
-
Unlimited credit reports download
-
Unlimited users
-
API access
-
CRM Integration
-
Dedicated account manager
Select your package
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
One report
-
Credit Rating and Limit Recomendations
-
5 years of financial statements
-
Directors and shareholders
-
Court Judgements
-
Global Group Structure
-
Trade Payment
Unlimited reports
-
Everything include in one report, plus
-
Unlimited credit reports download
-
Unlimited users
-
API access
-
CRM Integration
-
Dedicated account manager
Select your package
